Table 2.
Clinicopathologic data for colorectal cancer patients treated with adjuvant chemotherapy
| Clinicopathologic data | Total (n = 130) |
| Median age (range) | 67 (37-88) |
| Male | 79 (60.8) |
| Primary site | |
| Rectum | 60 (46.2) |
| Positive lymph nodes | 76 (58.5) |
| Stage according to AJCC | |
| I | 1 (0.8) |
| II | 54 (41.5) |
| III | 75 (57.7) |
| Histological grade | |
| I + II | 83 (63.8) |
| III + IV | 47 (36.2) |
| KRAS mutation | 48 (36.9) |
| BRAF V600E mutation | 5 (3.8) |
| TYMS LOH | 34 (26.2) |
| Overall survival | |
| Deaths n (%) | 45 (34.6) |
| Mean time month (95%CI) | 110.0 (99.5-120.5) |
| Disease-free survival | |
| Events n (%) | 51 (39.2) |
| Mean time month (95%CI) | 100.1 (88.3-112.0) |
| Median follow up in months (range) | 71.2 (0.5-156.8) |
AJCC: American Joint Committee on Cancer 7th edition; TYMS: Thymidylate synthase gene; LOH: Loss of heterozygosity; CI: Confidence interval.